Definium Therapeutics, Inc. is 2.5x more valuable than Cronos Group Inc. by market capitalization ($2.53 B vs $1.02 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | DFTX | CRON |
|---|---|---|
| Market cap | $2.53 B | $1.02 B |
| US-listed rank | #1936 | #2616 |
| Revenue (latest FY) | - | $146.59M |
| Net income (latest FY) | -$183.79M | -$2.90M |
| Net margin | - | -2.0% |
| SEC filings | 445 | 486 |
Definium Therapeutics, Inc. is 2.5x more valuable than Cronos Group Inc. by market capitalization ($2.53 B vs $1.02 B).
Full pages: Definium Therapeutics, Inc. and Cronos Group Inc., or browse the full rankings.